{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:08:36Z","timestamp":1791216516711,"version":"4.1.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"7","license":[{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T00:00:00Z","timestamp":1717545600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100000196","name":"Canada Foundation for Innovation","doi-asserted-by":"publisher","award":["225404, 30865"],"award-info":[{"award-number":["225404, 30865"]}],"id":[{"id":"10.13039\/501100000196","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012171","name":"Ontario Research Foundation","doi-asserted-by":"publisher","award":["RDI34876, E10-020"],"award-info":[{"award-number":["RDI34876, E10-020"]}],"id":[{"id":"10.13039\/100012171","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003725","name":"National Research Foundation of Korea","doi-asserted-by":"publisher","award":["KRF-2021R1A6A1A03038899"],"award-info":[{"award-number":["KRF-2021R1A6A1A03038899"]}],"id":[{"id":"10.13039\/501100003725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000142","name":"Arthritis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000142","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Immunol"],"DOI":"10.1038\/s41423-024-01183-5","type":"journal-article","created":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T08:04:52Z","timestamp":1717574692000},"page":"770-786","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["HIF-1\u03b1 and MIF enhance neutrophil-driven type 3 immunity and chondrogenesis in a murine spondyloarthritis model"],"prefix":"10.1038","volume":"21","author":[{"given":"Akihiro","family":"Nakamura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3034-5029","authenticated-orcid":false,"given":"Sungsin","family":"Jo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sayaka","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mansi K.","family":"Aparnathi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaghayegh Foroozan","family":"Boroojeni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariia","family":"Korshko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye-Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Himanshi","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Vijayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason S.","family":"Rockel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohit","family":"Kapoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Igor","family":"Jurisica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tae-Hwan","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigil","family":"Haroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,6,5]]},"reference":[{"key":"1183_CR1","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1038\/nrrheum.2017.56","volume":"13","author":"V Ranganathan","year":"2017","unstructured":"Ranganathan V, Gracey E, Brown MA, Inman RD, Haroon N. Pathogenesis of ankylosing spondylitis - recent advances and future directions. Nat Rev Rheumatol. 2017;13:359\u201367.","journal-title":"Nat Rev Rheumatol"},{"key":"1183_CR2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41584-018-0091-8","volume":"14","author":"EM Gravallese","year":"2018","unstructured":"Gravallese EM, Schett G. Effects of the IL-23-IL-17 pathway on bone in spondyloarthritis. Nat Rev Rheumatol. 2018;14:631\u201340.","journal-title":"Nat Rev Rheumatol"},{"key":"1183_CR3","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11926-021-00995-y","volume":"23","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Haroon N. Recent updates in the immunopathology of type 3 immunity-mediated enthesitis. Curr Rheumatol Rep. 2021;23:31.","journal-title":"Curr Rheumatol Rep"},{"key":"1183_CR4","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/rheumatology\/key375","volume":"58","author":"J Braun","year":"2019","unstructured":"Braun J, Baraliakos X, Deodhar A, Poddubnyy D, Emery P, Delicha EM, et al. Secukinumab shows sustained efficacy and low structural progression in ankylosing spondylitis: 4-year results from the MEASURE 1 study. Rheumatology. 2019;58:859\u201368.","journal-title":"Rheumatology"},{"key":"1183_CR5","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/S0140-6736(20)30265-8","volume":"395","author":"A Deodhar","year":"2020","unstructured":"Deodhar A, Helliwell PS, Boehncke W-H, Kollmeier AP, Hsia EC, Subramanian RA, et al. Guselkumab in patients with active psoriatic arthritis who were biologic-naive or had previously received TNF\u03b1 inhibitor treatment (DISCOVER-1): a double-blind, randomised, placebo-controlled phase 3 trial. Lancet. 2020;395:1115\u201325.","journal-title":"Lancet"},{"key":"1183_CR6","volume":"13","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Zeng F, Nakamura S, Reid KT, Gracey E, Lim M, et al. Macrophage migration inhibitory factor drives pathology in a mouse model of spondyloarthritis and is associated with human disease. Sci Transl Med. 2021;13:eabg1210.","journal-title":"Sci Transl Med"},{"key":"1183_CR7","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/s41584-019-0238-2","volume":"15","author":"I Kang","year":"2019","unstructured":"Kang I, Bucala R. The immunobiology of MIF: function, genetics and prospects for precision medicine. Nat Rev Rheumatol. 2019;15:427\u201337.","journal-title":"Nat Rev Rheumatol"},{"key":"1183_CR8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1007\/s00223-021-00933-1","volume":"110","author":"W Lems","year":"2022","unstructured":"Lems W, Miceli-Richard C, Haschka J, Giusti A, Chistensen GL, Kocijan R, et al. Bone involvement in patients with spondyloarthropathies. Calcif Tissue Int. 2022;110:393\u2013420.","journal-title":"Calcif Tissue Int"},{"key":"1183_CR9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.55563\/clinexprheumatol\/9ljng7","volume":"40","author":"A Neto","year":"2022","unstructured":"Neto A, Pinheiro Torres R, Ramiro S, Sardoo A, Rodrigues-Manica S, Lagoas-Gomes J, et al. Muscle dysfunction in axial spondylarthritis: the MyoSpA study. Clin Exp Rheumatol. 2022;40:267\u201373.","journal-title":"Clin Exp Rheumatol"},{"key":"1183_CR10","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/art.30393","volume":"63","author":"P Chiowchanwisawakit","year":"2011","unstructured":"Chiowchanwisawakit P, Lambert RGW, Conner-Spady B, Maksymowych WP. Focal fat lesions at vertebral corners on magnetic resonance imaging predict the development of new syndesmophytes in ankylosing spondylitis. Arthritis Rheum. 2011;63:2215\u201325.","journal-title":"Arthritis Rheum"},{"key":"1183_CR11","first-page":"S81","volume":"5 Suppl 1","author":"H Mielants","year":"1987","unstructured":"Mielants H, Veys EM, Cuvelier C, de Vos M, Joos R. Significance of gut inflammation in the seronegative spondyloarthropathies. Clin Exp Rheumatol. 1987;5 Suppl 1:S81\u20137.","journal-title":"Clin Exp Rheumatol"},{"key":"1183_CR12","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/s13075-015-0675-5","volume":"17","author":"J Bleil","year":"2015","unstructured":"Bleil J, Sieper J, Maier R, Schlichting U, Hempfing A, Syrbe U, et al. Cartilage in facet joints of patients with ankylosing spondylitis (AS) shows signs of cartilage degeneration rather than chondrocyte hypertrophy: implications for joint remodeling in AS. Arthritis Res Ther. 2015;17:170.","journal-title":"Arthritis Res Ther"},{"key":"1183_CR13","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1038\/s41413-021-00140-6","volume":"9","author":"T Yu","year":"2021","unstructured":"Yu T, Zhang J, Zhu W, Wang X, Bai Y, Feng B, et al. Chondrogenesis mediates progression of ankylosing spondylitis through heterotopic ossification. Bone Res. 2021;9:19.","journal-title":"Bone Res"},{"key":"1183_CR14","doi-asserted-by":"crossref","first-page":"R359","DOI":"10.1186\/ar1501","volume":"7","author":"D Baeten","year":"2005","unstructured":"Baeten D, Kruithof E, de Rycke L, Boots AM, Mielants H, Veys EM, et al. Infiltration of the synovial membrane with macrophage subsets and polymorphonuclear cells reflects global disease activity in spondyloarthropathy. Arthritis Res Ther. 2005;7:R359\u201369.","journal-title":"Arthritis Res Ther"},{"key":"1183_CR15","doi-asserted-by":"crossref","first-page":"6852","DOI":"10.4238\/2015.June.18.28","volume":"14","author":"KG Liu","year":"2015","unstructured":"Liu KG, He QH, Tan JW, Liao GJ. Expression of TNF-\u03b1, VEGF, and MMP-3 mRNAs in synovial tissues and their roles in fibroblast-mediated osteogenesis in ankylosing spondylitis. Genet Mol Res. 2015;14:6852\u20138.","journal-title":"Genet Mol Res"},{"key":"1183_CR16","doi-asserted-by":"crossref","first-page":"409","DOI":"10.7326\/M14-2470","volume":"163","author":"NN Haroon","year":"2015","unstructured":"Haroon NN, Paterson JM, Li P, Inman RD, Haroon N. Patients with ankylosing spondylitis have increased cardiovascular and cerebrovascular mortality: a population-based study. Ann Intern Med. 2015;163:409\u201316.","journal-title":"Ann Intern Med"},{"key":"1183_CR17","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1111\/1756-185X.13912","volume":"23","author":"C-H Chen","year":"2020","unstructured":"Chen C-H, Chen H-A, Liu C-H, Liao H-T, Chou C-T, Chen C-H. Association of obesity with inflammation, disease severity and cardiovascular risk factors among patients with ankylosing spondylitis. Int J Rheum Dis. 2020;23:1165\u201374.","journal-title":"Int J Rheum Dis"},{"key":"1183_CR18","doi-asserted-by":"crossref","DOI":"10.15252\/embr.202153035","volume":"22","author":"K Nishikawa","year":"2021","unstructured":"Nishikawa K, Seno S, Yoshihara T, Narazaki A, Sugiura Y, Shimizu R, et al. Osteoclasts adapt to physioxia perturbation through DNA demethylation. EMBO Rep. 2021;22:e53035.","journal-title":"EMBO Rep"},{"key":"1183_CR19","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1056\/NEJMra0910283","volume":"364","author":"HK Eltzschig","year":"2011","unstructured":"Eltzschig HK, Carmeliet P. Hypoxia and inflammation. N Engl J Med. 2011;364:656\u201365.","journal-title":"N Engl J Med"},{"key":"1183_CR20","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1113\/jphysiol.2008.157669","volume":"586","author":"CT Taylor","year":"2008","unstructured":"Taylor CT. Interdependent roles for hypoxia inducible factor and nuclear factor-kappaB in hypoxic inflammation. J Physiol. 2008;586:4055\u20139.","journal-title":"J Physiol"},{"key":"1183_CR21","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molmed.2018.10.006","volume":"25","author":"ER Watts","year":"2019","unstructured":"Watts ER, Walmsley SR. Inflammation and Hypoxia: HIF and PHD Isoform Selectivity. Trends Mol Med. 2019;25:33\u201346.","journal-title":"Trends Mol Med"},{"key":"1183_CR22","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/j.eururo.2018.09.030","volume":"75","author":"Q Fu","year":"2019","unstructured":"Fu Q, Xu L, Wang Y, Jiang Q, Liu Z, Zhang J, et al. Tumor-associated macrophage-derived interleukin-23 interlinks kidney cancer glutamine addiction with immune evasion. Eur Urol. 2019;75:752\u201363.","journal-title":"Eur Urol"},{"key":"1183_CR23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1158\/1535-7163.MCT-07-0463","volume":"7","author":"MY Koh","year":"2008","unstructured":"Koh MY, Spivak-Kroizman T, Venturini S, Welsh S, Williams RR, Kirkpatrick DL, et al. Molecular mechanisms for the activity of PX-478, an antitumor inhibitor of the hypoxia-inducible factor-1alpha. Mol Cancer Ther. 2008;7:90\u2013100.","journal-title":"Mol Cancer Ther"},{"key":"1183_CR24","doi-asserted-by":"crossref","first-page":"1755","DOI":"10.1002\/art.38638","volume":"66","author":"H Benham","year":"2014","unstructured":"Benham H, Rehaume LM, Hasnain SZ, Velasco J, Baillet AC, Ruutu M, et al. Interleukin-23 mediates the intestinal response to microbial \u03b2-1,3-glucan and the development of spondyloarthritis pathology in SKG mice. Arthritis Rheumatol. 2014;66:1755\u201367.","journal-title":"Arthritis Rheumatol"},{"key":"1183_CR25","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1002\/art.41653","volume":"73","author":"X Romand","year":"2021","unstructured":"Romand X, Liu X, Rahman MA, Bhuyan ZA, Douillard C, Kedia RA, et al. Mediation of interleukin-23 and tumor necrosis factor-driven reactive arthritis by chlamydia-infected macrophages in SKG mice. Arthritis Rheumatol. 2021;73:1200\u201310.","journal-title":"Arthritis Rheumatol"},{"key":"1183_CR26","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1002\/art.34423","volume":"64","author":"M Ruutu","year":"2012","unstructured":"Ruutu M, Thomas G, Steck R, Degli-Esposti MA, Zinkernagel MS, Alexander K, et al. beta-glucan triggers spondylarthritis and Crohn\u2019s disease-like ileitis in SKG mice. Arthritis Rheum. 2012;64:2211\u201322.","journal-title":"Arthritis Rheum"},{"key":"1183_CR27","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.3389\/fimmu.2018.02262","volume":"9","author":"S Bezdek","year":"2018","unstructured":"Bezdek S, Leng L, Busch H, Mousavi S, Rades D, Dahlke M, et al. Macrophage migration inhibitory factor (MIF) drives murine psoriasiform dermatitis. Front Immunol. 2018;9:2262.","journal-title":"Front Immunol"},{"key":"1183_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/JCI126567","author":"E Gracey","year":"2020","unstructured":"Gracey E, Hromadova D, Lim M, Qaiyum Z, Zeng M, Yao Y, et al. TYK2 inhibition reduces type 3 immunity and modifies disease progression in murine spondyloarthritis. J Clin Investig. 2020. https:\/\/doi.org\/10.1172\/JCI126567.","journal-title":"J Clin Investig"},{"key":"1183_CR29","volume":"8","author":"MH Al-Mossawi","year":"2017","unstructured":"Al-Mossawi MH, Chen L, Fang H, Ridley A, de Wit J, Yager N, et al. Unique transcriptome signatures and GM-CSF expression in lymphocytes from patients with spondyloarthritis. Nat Commun. 2017;8:1510.","journal-title":"Nat Commun"},{"key":"1183_CR30","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1038\/nm.2817","volume":"18","author":"JP Sherlock","year":"2012","unstructured":"Sherlock JP, Joyce-Shaikh B, Turner SP, Chao C-C, Sathe M, Grein J, et al. IL-23 induces spondyloarthropathy by acting on ROR-\u03b3t+ CD3+CD4-CD8- entheseal resident T cells. Nat Med. 2012;18:1069\u201376.","journal-title":"Nat Med"},{"key":"1183_CR31","volume":"12","author":"F Shao","year":"2021","unstructured":"Shao F, Liu Q, Zhu Y, Fan Z, Chen W, Liu S, et al. Targeting chondrocytes for arresting bony fusion in ankylosing spondylitis. Nat Commun. 2021;12:6540.","journal-title":"Nat Commun"},{"key":"1183_CR32","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11926-022-01081-7","volume":"24","author":"B Wu","year":"2022","unstructured":"Wu B, Nakamura A. Deep insight into the role of MIF in spondyloarthritis. Curr Rheumatol Rep. 2022;24:269\u201378.","journal-title":"Curr Rheumatol Rep"},{"key":"1183_CR33","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-03124-z","volume":"9","author":"O Duchamp de Lageneste","year":"2018","unstructured":"Duchamp de Lageneste O, Julien A, Abou-Khalil R, Frangi G, Carvalho C, Cagnard N, et al. Periosteum contains skeletal stem cells with high bone regenerative potential controlled by Periostin. Nat Commun. 2018;9:773.","journal-title":"Nat Commun"},{"key":"1183_CR34","volume":"7","author":"K Howell","year":"2017","unstructured":"Howell K, Chien C, Bell R, Laudier D, Tufa SF, Keene DR, et al. Novel model of tendon regeneration reveals distinct cell mechanisms underlying regenerative and fibrotic tendon healing. Sci Rep. 2017;7:45238.","journal-title":"Sci Rep"},{"key":"1183_CR35","doi-asserted-by":"crossref","first-page":"335","DOI":"10.15283\/ijsc20091","volume":"13","author":"G-I Im","year":"2020","unstructured":"Im G-I, Kim T-K. Stem cells for the regeneration of tendon and ligament: a perspective. Int J Stem Cells. 2020;13:335\u201341.","journal-title":"Int J Stem Cells"},{"key":"1183_CR36","doi-asserted-by":"crossref","first-page":"31079","DOI":"10.1074\/jbc.M602296200","volume":"281","author":"M Hirao","year":"2006","unstructured":"Hirao M, Tamai N, Tsumaki N, Yoshikawa H, Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem. 2006;281:31079\u201392.","journal-title":"J Biol Chem"},{"key":"1183_CR37","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.1016\/j.celrep.2016.05.055","volume":"15","author":"Y Shwartz","year":"2016","unstructured":"Shwartz Y, Viukov S, Krief S, Zelzer E. Joint development involves a continuous influx of Gdf5-positive cells. Cell Rep. 2016;15:2577\u201387.","journal-title":"Cell Rep"},{"key":"1183_CR38","doi-asserted-by":"crossref","first-page":"3855","DOI":"10.1242\/dev.128.19.3855","volume":"128","author":"R Schweitzer","year":"2001","unstructured":"Schweitzer R, Chyung JH, Murtaugh LC, Brent AE, Rosen V, Olson EN, et al. Analysis of the tendon cell fate using Scleraxis, a specific marker for tendons and ligaments. Development. 2001;128:3855\u201366.","journal-title":"Development"},{"key":"1183_CR39","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1136\/annrheumdis-2018-214381","volume":"78","author":"Rehaume LM","year":"2019","unstructured":"Rehaume LM, Matigian N, Mehdi AM, Lachner N, Bowerman KL, Daly J, et al. IL-23 favours outgrowth of spondyloarthritis-associated pathobionts and suppresses host support for homeostatic microbiota. Ann Rheum Dis. 2019;78:494\u2013503.","journal-title":"Ann Rheum Dis"},{"key":"1183_CR40","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1136\/annrheumdis-2018-214944","volume":"78","author":"C Bridgewood","year":"2019","unstructured":"Bridgewood C, Watad A, Russell T, Palmer TM, Marzo-Ortega H, Khan A, et al. Identification of myeloid cells in the human enthesis as the main source of local IL-23 production. Ann Rheum Dis. 2019;78:929\u201333.","journal-title":"Ann Rheum Dis"},{"key":"1183_CR41","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1136\/annrheumdis-2012-202925","volume":"73","author":"F Ciccia","year":"2014","unstructured":"Ciccia F, Accardo-Palumbo A, Rizzo A, Guggino G, Raimondo S, Giardina A, et al. Evidence that autophagy, but not the unfolded protein response, regulates the expression of IL-23 in the gut of patients with ankylosing spondylitis and subclinical gut inflammation. Ann Rheum Dis. 2014;73:1566\u201374.","journal-title":"Ann Rheum Dis"},{"key":"1183_CR42","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1186\/s13075-016-0998-x","volume":"18","author":"AT Shaw","year":"2016","unstructured":"Shaw AT, Maeda Y, Gravallese EM. IL-17A deficiency promotes periosteal bone formation in a model of inflammatory arthritis. Arthritis Res Ther. 2016;18:104.","journal-title":"Arthritis Res Ther"},{"key":"1183_CR43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/ng.513","volume":"42","author":"JD Reveille","year":"2010","unstructured":"Reveille JD, Sims A-M, Danoy P, Evans DM, Leo P, Pointon JJ, et al. Genome-wide association study of ankylosing spondylitis identifies non-MHC susceptibility loci. Nat Genet. 2010;42:123\u20137.","journal-title":"Nat Genet"},{"key":"1183_CR44","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1038\/ng.717","volume":"42","author":"A Franke","year":"2010","unstructured":"Franke A, McGovern DPB, Barrett JC, Wang K, Radford-Smith GL, Ahmad T, et al. Genome-wide meta-analysis increases to 71 the number of confirmed Crohn\u2019s disease susceptibility loci. Nat Genet. 2010;42:1118\u201325.","journal-title":"Nat Genet"},{"key":"1183_CR45","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/j.bbrc.2018.03.144","volume":"499","author":"X Xu","year":"2018","unstructured":"Xu X, Yang C, Chen J, Liu J, Li P, Shi Y, et al. Interleukin-23 promotes the migration and invasion of gastric cancer cells by inducing epithelial-to-mesenchymal transition via the STAT3 pathway. Biochem Biophys Res Commun. 2018;499:273\u20138.","journal-title":"Biochem Biophys Res Commun"},{"key":"1183_CR46","first-page":"3210","volume":"125","author":"S Ohta","year":"2012","unstructured":"Ohta S, Misawa A, Fukaya R, Inoue S, Kanemura Y, Okano H, et al. Macrophage migration inhibitory factor (MIF) promotes cell survival and proliferation of neural stem\/progenitor cells. J Cell Sci. 2012;125:3210\u201320.","journal-title":"J Cell Sci"},{"key":"1183_CR47","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1038\/s42003-021-02944-y","volume":"5","author":"NQ Liu","year":"2022","unstructured":"Liu NQ, Lin Y, Li L, Lu J, Geng D, Zhang J, et al. gp130\/STAT3 signaling is required for homeostatic proliferation and anabolism in postnatal growth plate and articular chondrocytes. Commun Biol. 2022;5:64.","journal-title":"Commun Biol"},{"key":"1183_CR48","doi-asserted-by":"crossref","first-page":"3923","DOI":"10.1093\/rheumatology\/keaa846","volume":"60","author":"S Jo","year":"2021","unstructured":"Jo S, Won EJ, Kim M-J, Lee YJ, Jin S-H, Park P-R, et al. STAT3 phosphorylation inhibition for treating inflammation and new bone formation in ankylosing spondylitis. Rheumatology. 2021;60:3923\u201335.","journal-title":"Rheumatology"},{"key":"1183_CR49","doi-asserted-by":"crossref","first-page":"3076","DOI":"10.1200\/jco.2010.28.15_suppl.3076","volume":"28","author":"R Tibes","year":"2010","unstructured":"Tibes R, Falchook GS, von Hoff DD, Weiss GJ, Iyengar T, Kurzrock R, et al. Results from a phase I, dose-escalation study of PX-478, an orally available inhibitor of HIF-1\u03b1. J Clin Oncol. 2010;28:3076.","journal-title":"J Clin Oncol"},{"key":"1183_CR50","doi-asserted-by":"publisher","unstructured":"Chen P-M, Wilson PC, Shyer JA, Veselits M, Steach HR, Cui C, et al. Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis. Sci Transl Med. 2020;12. https:\/\/doi.org\/10.1126\/scitranslmed.aay1620.","DOI":"10.1126\/scitranslmed.aay1620"},{"key":"1183_CR51","doi-asserted-by":"crossref","first-page":"E338","DOI":"10.1073\/pnas.1515397113","volume":"113","author":"S Agarwal","year":"2016","unstructured":"Agarwal S, Loder S, Brownley C, Cholok D, Mangiavini L, Li J, et al. Inhibition of Hif1\u03b1 prevents both trauma-induced and genetic heterotopic ossification. Proc Natl Acad Sci USA. 2016;113:E338\u201347.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1183_CR52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1136\/ard.32.6.487","volume":"32","author":"MJ Kendall","year":"1973","unstructured":"Kendall MJ, Farr M, Meynell MJ, Hawkins CF. Synovial fluid in ankylosing spondylitis. Ann Rheum Dis. 1973;32:487\u201392.","journal-title":"Ann Rheum Dis"},{"key":"1183_CR53","unstructured":"Rosenzweig H, Vance E, sen R, Caplan L NR. A Role for Neutrophils in Disease Onset and Severity of Spondyloarthritis [abstract]. Arthritis Rheumatol. 2021;73. https:\/\/acrabstracts.org\/abstract\/a-role-for-neutrophils-in-disease-onset-and-severity-of-spondyloarthritis\/."},{"key":"1183_CR54","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1016\/j.jaci.2018.01.003","volume":"141","author":"Y Souwer","year":"2018","unstructured":"Souwer Y, Groot Kormelink T, Taanman-Kueter EW, Muller FJ, van Capel TMM, Varga DV, et al. Human T(H)17 cell development requires processing of dendritic cell-derived CXCL8 by neutrophil elastase. J Allergy Clin Immunol. 2018;141:2286\u20132289.e5.","journal-title":"J Allergy Clin Immunol"},{"key":"1183_CR55","doi-asserted-by":"crossref","unstructured":"Rosenzweig HL, Vance EE, Asare-Konadu K, Koney K V, Lee EJ, Deodhar AA, et al. Card9\/neutrophil signalling axis promotes IL-17A-mediated ankylosing spondylitis. Ann Rheum Dis. 2023;83:ard-2022-223146.","DOI":"10.1136\/ard-2022-223146"},{"key":"1183_CR56","first-page":"2605","volume":"7","author":"R Morales-Zambrano","year":"2014","unstructured":"Morales-Zambrano R, Bautista-Herrera LA, De la Cruz-Mosso U, Villanueva-Quintero GD, Padilla-Guti\u00e9rrez JR, Valle Y, et al. Macrophage migration inhibitory factor (MIF) promoter polymorphisms (-794 CATT5-8 and -173 G>C): association with MIF and TNF\u03b1 in psoriatic arthritis. Int J Clin Exp Med. 2014;7:2605\u201314.","journal-title":"Int J Clin Exp Med"},{"key":"1183_CR57","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1093\/rheumatology\/keq102","volume":"49","author":"L Eder","year":"2010","unstructured":"Eder L, Chandran V, Ueng J, Bhella S, Lee K-A, Rahman P, et al. Predictors of response to intra-articular steroid injection in psoriatic arthritis. Rheumatology. 2010;49:1367\u201373.","journal-title":"Rheumatology"},{"key":"1183_CR58","doi-asserted-by":"crossref","first-page":"579","DOI":"10.46497\/ArchRheumatol.2023.9898","volume":"38","author":"Y Kili\u00e7","year":"2023","unstructured":"Kili\u00e7 Y, Guzel Erdogan D, Baykul M, Nas K. Examining the functions of the vascular endothelial growth factor\/hypoxia-inducible factor signaling pathway in psoriatic arthritis. Arch Rheumatol. 2023;38:579\u201389.","journal-title":"Arch Rheumatol"},{"key":"1183_CR59","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.joca.2021.11.013","volume":"30","author":"S Jo","year":"2022","unstructured":"Jo S, Lee JS, Nam B, Lee YL, Kim H, Lee EY, et al. SOX9+ enthesis cells are associated with spinal ankylosis in ankylosing spondylitis. Osteoarthr Cartil. 2022;30:280\u201390.","journal-title":"Osteoarthr Cartil"},{"key":"1183_CR60","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1186\/s13075-020-02327-4","volume":"22","author":"E Christodoulou-Vafeiadou","year":"2020","unstructured":"Christodoulou-Vafeiadou E, Geka C, Ntari L, Kranidioti K, Argyropoulou E, Meier F, et al. Ectopic bone formation and systemic bone loss in a transmembrane TNF-driven model of human spondyloarthritis. Arthritis Res Ther. 2020;22:232.","journal-title":"Arthritis Res Ther"},{"key":"1183_CR61","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s13075-021-02693-7","volume":"24","author":"Z Stavre","year":"2022","unstructured":"Stavre Z, Bridgewood C, Zhou Q, Maeda Y, Huang T-T, Karman J, et al. A role for neutrophils in early enthesitis in spondyloarthritis. Arthritis Res Ther. 2022;24:24.","journal-title":"Arthritis Res Ther"},{"key":"1183_CR62","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.stemcr.2016.07.003","volume":"7","author":"Y Yao","year":"2016","unstructured":"Yao Y, Deng Q, Song W, Zhang H, Li Y, Yang Y, et al. MIF plays a key role in regulating tissue-specific chondro-osteogenic differentiation fate of human cartilage endplate stem cells under hypoxia. Stem Cell Rep. 2016;7:249\u201362.","journal-title":"Stem Cell Rep"},{"key":"1183_CR63","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1136\/annrheumdis-2018-213328","volume":"77","author":"D Baeten","year":"2018","unstructured":"Baeten D, \u00d8stergaard M, Wei JCC, Sieper J, J\u00e4rvinen P, Tam LS, et al. Risankizumab, an IL-23 inhibitor, for ankylosing spondylitis: Results of a randomised, double-blind, placebo-controlled, proof-of-concept, dose-finding phase 2 study. Ann Rheum Dis. 2018;77:1295\u2013302.","journal-title":"Ann Rheum Dis"},{"key":"1183_CR64","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1002\/art.40728","volume":"71","author":"A Deodhar","year":"2019","unstructured":"Deodhar A, Gensler LS, Sieper J, Clark M, Calderon C, Wang Y, et al. Three multicenter, randomized, double-blind, placebo-controlled studies evaluating the efficacy and safety of ustekinumab in axial spondyloarthritis. Arthritis Rheumatol. 2019;71:258\u201370.","journal-title":"Arthritis Rheumatol"},{"key":"1183_CR65","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1093\/emboj\/17.11.3005","volume":"17","author":"HE Ryan","year":"1998","unstructured":"Ryan HE, Lo J, Johnson RS. HIF-1 alpha is required for solid tumor formation and embryonic vascularization. EMBO J. 1998;17:3005\u201315.","journal-title":"EMBO J"},{"key":"1183_CR66","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16596-9","volume":"11","author":"G Boivin","year":"2020","unstructured":"Boivin G, Faget J, Ancey P-B, Gkasti A, Mussard J, Engblom C, et al. Durable and controlled depletion of neutrophils in mice. Nat Commun. 2020;11:2762.","journal-title":"Nat Commun"},{"key":"1183_CR67","doi-asserted-by":"crossref","first-page":"D640","DOI":"10.1093\/nar\/gkab1034","volume":"50","author":"M Kotlyar","year":"2022","unstructured":"Kotlyar M, Pastrello C, Ahmed Z, Chee J, Varyova Z, Jurisica I. IID 2021: towards context-specific protein interaction analyses by increased coverage, enhanced annotation and enrichment analysis. Nucleic Acids Res. 2022;50:D640\u2013D647.","journal-title":"Nucleic Acids Res"},{"key":"1183_CR68","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.joca.2020.12.004","volume":"29","author":"A Nakamura","year":"2021","unstructured":"Nakamura A, Rampersaud YR, Sundararajan K, Nakamura S, Wu B, Matip E, et al. Zinc finger protein-440 promotes cartilage degenerative mechanisms in human facet and knee osteoarthritis chondrocytes. Osteoarthr Cartil. 2021;29:372\u20139.","journal-title":"Osteoarthr Cartil"},{"key":"1183_CR69","doi-asserted-by":"publisher","DOI":"10.1136\/annrheumdis-2018-213629","author":"A Nakamura","year":"2018","unstructured":"Nakamura A, Rampersaud YR, Nakamura S, Sharma A, Zeng F, Rossomacha E, et al. MicroRNA-181a-5p antisense oligonucleotides attenuate osteoarthritis in facet and knee joints. Ann Rheum Dis. 2018. https:\/\/doi.org\/10.1136\/annrheumdis-2018-213629.","journal-title":"Ann Rheum Dis"},{"key":"1183_CR70","doi-asserted-by":"publisher","unstructured":"Nakamura A, Rampersaud YR, Sharma A, Lewis SJ, Wu B, Datta P, et al. Identification of microRNA-181a-5p and microRNA-4454 as mediators of facet cartilage degeneration. JCI Insight. 2016. https:\/\/doi.org\/10.1172\/jci.insight.86820.","DOI":"10.1172\/jci.insight.86820"}],"container-title":["Cellular & Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01183-5","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01183-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T23:06:03Z","timestamp":1719702363000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41423-024-01183-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,5]]},"references-count":70,"journal-issue":{"issue":"7","published-online":{"date-parts":[[2024,7]]}},"alternative-id":["1183"],"URL":"https:\/\/doi.org\/10.1038\/s41423-024-01183-5","relation":{},"ISSN":["2042-0226"],"issn-type":[{"value":"2042-0226","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,5]]},"assertion":[{"value":"29 October 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 May 2024","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"AN and NH have filed a US provisional patent (METHODS OF TREATING SPONDYLOARTHRITIS AND SYMPTOMS THEREOF; No. 63\/106,859). AN has received speaker honorarium and\/or consultant fees from AbbVie, JAMP, and Novartis. NH has received consulting fees from AbbVie, Amgen, Eli Lilly, Janssen, Merck, Novartis and UCB.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}